Trial Profile
A study investigating efficacy of omalizumab for analysing healthcare resource utilization in patients with uncontrolled severe persistent allergic asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 18 Jan 2016 New trial record